Jhajjar (Haryana) [India], April 10 (HBTV): Boditech Med Inc., a leading South Korean multinational diagnostics firm, has inaugurated its manufacturing plant at the Model Economic Township (MET City) in Jhajjar, Haryana.

Model Economic Township Limited (METL) is a wholly owned subsidiary of Reliance Industries Limited.

The inauguration ceremony of Boditech Med’s state-of-the-art facility took place in the presence of Lee Seong-ho, Ambassador of the Republic of Korea to India, and Eui-Yeol Choi, Chairman and CEO of Boditech Med Inc.

Globally recognised for its Point-of-Care (POC) solutions in the in vitro diagnostics (IVD) sector, Boditech Med Inc. has set up the new manufacturing unit under its India subsidiary, Boditech Med India Pvt. Ltd.

In a statement, MET City announced that with this latest addition, it now hosts over 580 companies from 10 countries, including six South Korean enterprises.

The new Boditech Med facility aligns with the Government of India’s Make in India and Atmanirbhar Bharat initiatives.

‘Boditech Med’s state-of-the-art facility strengthens our position as an emerging hub for medical device manufacturing, and we look forward to welcoming more South Korean enterprises to our township at Jhajjar as India’s industrial landscape continues to evolve. Boditech Med’s investment is poised to create local employment, empower small businesses, and position MET City as a key node in the global medical devices value chain,’ said SV Goyal, CEO and WTD of MET City, in the statement.

Lee Seong-ho, Ambassador of the Republic of Korea to India, congratulated the company on the opening of the plant.

‘The Korea-India relationship is growing faster in India. Our government is committed to taking this relationship forward and ensuring its growth,’ he said.

‘I see growing signs of Korean companies’ interest in the Indian market. I hear and see many Korean companies showing interest in coming to the Indian market, expanding their Indian business. So I do believe in a matter of years, we are hoping to hopefully double, triple the Korean investment, Korean business activity, Korean people here in India,’ the envoy added.

Eui-Yeol Choi, Chairman and CEO of Boditech Med Inc., stated, ‘India represents both a crucial market and an emerging global manufacturing hub for medical devices. The country's supportive policy framework and growing healthcare infrastructure make it an ideal location for our expansion as we strengthen our commitment to the Indian market.’

Headquartered in Gangwon-do, South Korea, Boditech Med Inc. is publicly traded on KOSDAQ and operates in 140 countries, known for its cutting-edge in vitro diagnostics technologies.

(ANI)